9-[(tert-butoxy)carbonyl]-3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxylic acid, 95.0%, 250mg

3-Pyridylacetic Acid Hydrochloride>99.0%(T)10g

Depósito de muestras Visco, 300 ml, PTFE, FEP, 1 pieza

Methyl 2-formyl-4-hydroxybenzoate, 97%, 10g

2-(2-Methoxybenzoyl)-3-methylpyridine, 97.0%, 1g

(S)-tert-Butyl 5-bromo-2-((tert-butoxycarbonyl)amino)pentanoate, 95.0%, 50g

tert-Butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate, 95.0%, 5g

(11bR)-2,6-Bis(4-chlorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 250mg

4-PENTYLPHENYL 4-METHYLBENZOATE, 97.0%, 5g

[(3,4-dimethoxyphenyl)methyl](2-methylpropyl)amine, 95.0%, 10g

tert-Butyl 2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylate, 95%, 100mg

N,N-Diethyl-1,4-cyclohexanediamine (cis- and trans- mixture)>95.0%(GC)1g

4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95.0%, 1g